L‐Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q‐ syndrome in a TP53‐independent way

Haploinsufficiency of ribosomal proteins (RPs) and upregulation of the tumour suppressor TP53 have been shown to be the common basis for the anaemia observed in Diamond Blackfan anaemia and 5q‐ myelodysplastic syndrome. We previously demonstrated that treatment with L‐Leucine resulted in a marked improvement in anaemia in disease models. To determine if the L‐Leucine effect was Tp53‐dependent, we used antisense MOs to rps19 and rps14 in zebrafish; expression of tp53 and its downstream target cdkn1a remained elevated following L‐leucine treatment. We confirmed this observation in human CD34+ cells. L‐Leucine thus alleviates anaemia in RP‐deficient cells in a TP53‐independent manner.

[1]  A. Chakraborty,et al.  Ribosomal protein deficiency causes Tp53-independent erythropoiesis failure in zebrafish. , 2014, The international journal of biochemistry & cell biology.

[2]  S. Ellis,et al.  p53-Independent Cell Cycle and Erythroid Differentiation Defects in Murine Embryonic Stem Cells Haploinsufficient for Diamond Blackfan Anemia-Proteins: RPS19 versus RPL5 , 2014, PloS one.

[3]  G. Thomas,et al.  Loss of Tumor Suppressor RPL5/RPL11 Does Not Induce Cell Cycle Arrest but Impedes Proliferation Due to Reduced Ribosome Content and Translation Capacity , 2013, Molecular and Cellular Biology.

[4]  A. Khanna-Gupta.  Bone Marrow Failure Syndromes: The Ribosomopathies. , 2013, Journal of bone marrow research.

[5]  J. Boultwood,et al.  Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies. , 2013, Advances in biological regulation.

[6]  B. Paw,et al.  L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. , 2012, Blood.

[7]  S. Karlsson,et al.  Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia. , 2012, Blood.

[8]  U. Germing,et al.  Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts , 2012, Leukemia.

[9]  P. Rosenberg,et al.  Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. , 2012, Blood.

[10]  J. Kutok,et al.  Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. , 2011, Blood.

[11]  B. Ebert,et al.  Ribosomopathies: human disorders of ribosome dysfunction. , 2010, Blood.

[12]  T. Golub,et al.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen , 2007, Nature.

[13]  D. Pospíšilová,et al.  Successful treatment of a Diamond-Blackfan anemia patient with amino acid leucine. , 2007, Haematologica.

[14]  L. Zon,et al.  tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Leonard I Zon,et al.  Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants , 2003, Nature Immunology.